parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513

被引：15

作者：

Alonso, R ^{[1
]}

Galimand, M ^{[1
]}

Courvalin, P ^{[1
]}

机构：

[1] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 11期

关键词：

D O I：

10.1128/AAC.46.11.3686-3687.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：3686 / 3687

页数：2

共 11 条

[1] Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae:: Contributions of type II topoisomerase mutations and efflux to levels of resistance
Bast, DJ
Low, DE
Duncan, CL
Kilburn, L
Mandell, LA
Davidson, RJ
de Azavedo, JCS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 3049 - 3054
[2] Pathogenesis of group A streptococcal infections
Cunningham, MW
[J]. CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) : 470 - +
[3] Group A streptococci in the 1990s
Efstratiou, A
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 : 3 - 12
[4] Mechanisms of fluoroquinolone resistance
Hooper, DC
[J]. DRUG RESISTANCE UPDATES, 1999, 2 (01) : 38 - 55
[5] Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin
Li, XY
Zhao, XL
Drlica, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 522 - 524
[6] ISOLATION OF TRANSFORMATION-DEFICIENT STREPTOCOCCUS-PNEUMONIAE MUTANTS DEFECTIVE IN CONTROL OF COMPETENCE, USING INSERTION-DUPLICATION MUTAGENESIS WITH THE ERYTHROMYCIN RESISTANCE DETERMINANT OF PAM-BETA-1
MORRISON, DA
TROMBE, MC
HAYDEN, MK
WASZAK, GA
CHEN, JD
[J]. JOURNAL OF BACTERIOLOGY, 1984, 159 (03) : 870 - 876
[7] ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype
Munoz, R
DelaCampa, AG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) : 2252 - 2257
[8] Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, XS
Ambler, J
Mehtar, S
Fisher, LM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) : 2321 - 2326
[9] In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones
Schmitz, FJ
Boos, M
Mayer, S
Köhrer, K
Scheuring, S
Fluit, AC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 934 - 935
[10] Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae
Weigel, LM
Anderson, GJ
Facklam, RR
Tenover, FC
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3517 - 3523

← 1 2 →